The Left Ventricular Myocardium in Hypoplastic Left Heart Syndrome.

J Cardiovasc Dev Dis

Bioscience Institute, Faculty of Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne NE1 3BZ, UK.

Published: August 2022

Hypoplastic left heart syndrome (HLHS) is a collective term applied to severe congenital cardiac malformations, characterised by a combination of abnormalities mainly affecting the left ventricle, associated valves, and ascending aorta. Although in clinical practice HLHS is usually sub-categorised based on the patency of the mitral and aortic (left-sided) valves, it is also possible to comprehensively categorise HLHS into defined sub-groups based on the left ventricular morphology. Here, we discuss the published human-based studies of the ventricular myocardium in HLHS, evaluating whether the available evidence is in keeping with this ventricular morphology concept. Specifically, we highlight results from histological studies, indicating that the appearance of cardiomyocytes can be different based on the sub-group of HLHS. In addition, we discuss the histological appearances of endocardial fibroelastosis (EFE), which is a common feature of one specific sub-group of HLHS. Lastly, we suggest investigations that should ideally be undertaken using HLHS myocardial tissues at early stages of HLHS development to identify biological pathways and aid the understanding of HLHS aetiology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409828PMC
http://dx.doi.org/10.3390/jcdd9080279DOI Listing

Publication Analysis

Top Keywords

hlhs
9
left ventricular
8
ventricular myocardium
8
hypoplastic left
8
left heart
8
heart syndrome
8
ventricular morphology
8
sub-group hlhs
8
left
5
myocardium hypoplastic
4

Similar Publications

Patients With Hypoplastic Left Heart Syndrome Have a Shorter Superior Vena Cava.

Ann Thorac Surg Short Rep

September 2024

Biostatistics Unit, Department of Data Science, National Center for Child Health and Development, Tokyo, Japan.

Background: The primary treatment for hypoplastic left heart syndrome (HLHS) is the Fontan pathway, which entails performing the Glenn procedure. We hypothesized that the superior vena cava in patients with HLHS was short. As the length of the superior vena cava influences the Glenn procedure, we compared its length between patients with HLHS and those with other congenital heart diseases.

View Article and Find Full Text PDF

Hypoplastic left heart syndrome (HLHS) is a severe congenital heart disease associated with microcephaly and poor neurodevelopmental outcomes. Here we show that the Ohia HLHS mouse model, with mutations in Sap130, a chromatin modifier, and Pcdha9, a cell adhesion protein, also exhibits microcephaly associated with mitotic block and increased apoptosis leading to impaired cortical neurogenesis. Transcriptome profiling, DNA methylation, and Sap130 ChIPseq analyses all demonstrate dysregulation of genes associated with autism and cognitive impairment.

View Article and Find Full Text PDF

Proposal: Bold New Indications for Transcatheter Pulmonary Flow Restrictors.

Pediatr Cardiol

January 2025

Pediatric Heart Center, Johann-Wolfgang-Goethe University Clinic, Theodor-Storm-Kai 7, 60596, Frankfurt, Germany.

This proposal presents a proof of concept for the use of pulmonary flow restrictors (PFRs) based on MVP™-devices, drawing from clinical experience, and explores their potential role in the management of newborns with hypoplastic left heart syndrome (HLHS), other complex left heart lesions, and infants with end-stage dilated cardiomyopathy (DCM). At this early stage of age, manually adjusted PFRs can be tailored to patient's size and hemodynamic needs. Although currently used off-label, PFRs have substantial potential to improve outcomes in these vulnerable patient populations.

View Article and Find Full Text PDF

Background: Children with univentricular heart (UVH) have a limited life expectancy without early treatment. Long-term survival in UVH, in an unselected nationwide cohort, is unclear.

Objectives: To determine long-term survival in patients with UVH including non-operated patients compared with a control population in Sweden.

View Article and Find Full Text PDF
Article Synopsis
  • Atypical basic helix-loop-helix (bHLH) transcription factors, specifically OsAIF1 and OsAIF2, play crucial roles as negative regulators in brassinosteroid (BR) signaling, affecting rice (Oryza sativa) growth and development.
  • Genetic studies show that knockout of OsAIF1 and OsAIF2 leads to increased sensitivity to BR and changes in leaf inclination and grain size, while their overexpression reduces BR sensitivity.
  • The interaction between these atypical bHLHs and the positive regulator OsbHLH92 forms a triantagonistic relationship that fine-tunes leaf angle and grain size through the modulation of BR signaling.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!